Cite

    Haris Zahoor et al.. “Patterns, predictors and subsequent outcomes of disease progression in metastatic renal cell carcinoma patients treated with nivolumab.” Journal for immunotherapy of cancer, vol. 6, no. 1, 2018, p. . http://access.bl.uk/ark:/81055/vdc_100144509808.0x000010